A randomized, partially-blinded, single-dose, 4-way crossover study to evaluate the efficacy, safety, tolerability and pharmacokinetics of orally inhaled indacaterol maleate administered via the Concept1 device or as a PulmoSphere® formulation via the Simoon device.

Trial Profile

A randomized, partially-blinded, single-dose, 4-way crossover study to evaluate the efficacy, safety, tolerability and pharmacokinetics of orally inhaled indacaterol maleate administered via the Concept1 device or as a PulmoSphere® formulation via the Simoon device.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Oct 2012

At a glance

  • Drugs Indacaterol; Indacaterol
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Apr 2012 Official Title amended as reported by European Clinical Trials Database record.
    • 06 May 2010 Additional trial locations identified as reported by ClinicalTrials.gov.
    • 06 May 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top